Last reviewed · How we verify
PYRIDOXAL — Competitive Intelligence Brief
marketed
Vitamin C [EPC]
Aldehyde oxidase
Other
Small molecule
Live · refreshed every 30 min
Target snapshot
PYRIDOXAL (PYRIDOXAL).
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| PYRIDOXAL TARGET | PYRIDOXAL | marketed | Vitamin C [EPC] | Aldehyde oxidase | ||
| Norvasc | amlodipine | Pfizer Inc. | marketed | Calcium channel blocker (dihydropyridine) | Aldehyde oxidase, Voltage-dependent calcium channel gamma-1 subunit, 5-hydroxytryptamine receptor 6 | 1992-07-31 |
| Zofran | ondansetron | GSK (originally Glaxo) | marketed | 5-HT3 receptor antagonist (antiemetic) | Aldehyde oxidase, 5-hydroxytryptamine receptor 3B, Multidrug and toxin extrusion protein 1 | 1991-01-04 |
| Menadion | MENADIONE | Eli Lilly | marketed | Vitamin D [EPC] | Aldehyde oxidase, Alpha-synuclein, Dual specificity phosphatase Cdc25A | 1982-01-01 |
| Nizoral | ketoconazole | Johnson & Johnson (Janssen) | marketed | Azole Antifungal [EPC] | Aldehyde oxidase, Cytochrome P450 21, Sodium/nucleoside cotransporter 1 | 1981-06-26 |
| Motilium | domperidone | Johnson & Johnson (Janssen) | marketed | Prokinetic agent / Antiemetic | Aldehyde oxidase, Multidrug and toxin extrusion protein 1, Multidrug and toxin extrusion protein 2 | 1978-01-01 |
| Nolvadex | tamoxifen | AstraZeneca (originally ICI) | marketed | SERM (Selective estrogen receptor modulator) | Aldehyde oxidase, 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase, 5-hydroxytryptamine receptor 6 | 1977-12-30 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Vitamin C [EPC] class)
- · 16 drugs in this class
- Pfizer · 5 drugs in this class
- Energique, Inc. · 2 drugs in this class
- Exela Pharma · 1 drug in this class
- Faculdade de Medicina do ABC · 1 drug in this class
- Glaukos · 1 drug in this class
- Hippocration General Hospital · 1 drug in this class
- Jun Gong, MD · 1 drug in this class
- MEDPOINTE PHARM HLC · 1 drug in this class
- Novartis · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- PYRIDOXAL CI watch — RSS
- PYRIDOXAL CI watch — Atom
- PYRIDOXAL CI watch — JSON
- PYRIDOXAL alone — RSS
- Whole Vitamin C [EPC] class — RSS
Cite this brief
Drug Landscape (2026). PYRIDOXAL — Competitive Intelligence Brief. https://druglandscape.com/ci/pyridoxal. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing